Airtel shuts down 3G network in Kolkata
In one of the first phase-outs of 3G technology globally, Bharti Airtel announced the shutdown of its 3G network in Kolkata. Airtel mobile broadband services in the city will now be available on high-speed 4G.
Airtel has reframed the 900 MHz band spectrum being used for 3G to further strengthen its 4G network. The Company is deploying state-of-the-art L900 technology in the 900 MHz band to complement its 4G services in the 2300 Mhz and 1800 Mhz bands.
With L900, Airtel smartphone customers will enjoy improved 4G availability inside buildings - homes, offices and malls. It will also result in wider availability of Airtel 4G and superior network experience across Kolkata.
Wipro agrees to sell remaining 11% stake in WAISL for Rs55 lakh
Wipro said in the filing post market hours on Thursday that it has exited its joint venture WAISL by selling its 11% shareholding to Antariksh Softtech for Rs55 lakh.
WAISL, which was originally a Joint Venture (JV) between Wipro Limited (74%) and Delhi International Airport Limited (DIAL) (26%), provides various IT Services at Indira Gandhi International Airport, New Delhi, the company said in the press note.
Cox & Kings defaults on short-term debt repayment; trades at 52-week low
Shares of Cox & Kings touched 10% lower circuit at Rs36.45 on the BSE today. Cox & Kings said it has defaulted on the payment of commercial papers due to cash flow mismatch and a situation exacerbated by rating downgrade.
The company said it has defaulted on repayment of unsecured commercial paper. Out of the aggregate amount of Rs200cr, Rs50cr has been paid and the balance amount of Rs150cr has not been paid, the company said in the filing post market hours on Thursday.
Glenmark gets USFDA approval for Ezetimibe and Simvastatin
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, a generic version of Vytorin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, of MSD International GmbH.
In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
According to IQVIA sales data for the 12-month period ending April 2019, the Vytorin Tablets market achieved annual sales of approximately $92.4 million, the company said in the filing.
Power Grid to consider fund raising
Shares of Power Grid Corporation of India Ltd were trading flat at Rs208.45 on the BSE. The company said in the filing that the board of directors of the company is scheduled to meet on July 03, 2019.
Further, the board to consider and approve amongst other items of Agenda, an agenda to raise funds up to ~Rs10,000cr, from domestic market through issue of secured I unsecured, non-convertible, non-cumulative / cumulative, redeemable, taxable / tax-free Debentures / Bonds under Private Placement during the Financial Year 2020-21 in upto 20 tranches / offers, the company said in the filing.
Financial
Advisory Company in Indore, Stock
Advisory Company in Indore, Equity Tips, FreeTrading Tips , MCX Tips, sebi registered advisory company, Intraday
stock tips, Free
commodity tips
0 comments:
Post a Comment